Table 1.
Characteristic | Urinary dysfunction cohort (n = 800) | Erectile dysfunction cohort (n = 1003) |
---|---|---|
Patient age, yr | 62 (57–67) | 61 (56–65) |
| ||
Preoperative PSA, ng/ml | 5.1 (3.7–7.1) | 5.1 (3.7–6.9) |
| ||
Body mass index, kg/m2 | 28.1 (25.6–31.5) | 27.8 (25.5–30.7) |
| ||
Comorbidities | ||
0 | 225 (28) | 337 (34) |
1 | 252 (32) | 361 (36) |
2 | 211 (26) | 221 (22) |
≥3 | 112 (14) | 84 (8.4) |
| ||
Surgical approach | ||
Open | 273 (34) | 432 (43) |
Laparoscopic | 226 (28) | 289 (29) |
Robot assisted | 301 (38) | 282 (28) |
| ||
Nerve-sparing status | ||
None | 96 (12) | 78 (7.8) |
Unilateral | 137 (17) | 175 (17) |
Bilateral | 537 (67) | 742 (74) |
Unknown | 30 (3.8) | 8 (0.8) |
| ||
Pathologic stage | ||
T2 | 471 (59) | 610 (61) |
T3 or higher | 285 (36) | 339 (34) |
Unknown | 44 (5.5) | 54 (5.4) |
| ||
Pathologic Gleason score | ||
≤6 | 154 (19) | 196 (20) |
7 | 586 (73) | 750 (75) |
≥8 | 52 (6.5) | 52 (5.2) |
Unknown | 8 (1.0) | 5 (0.5) |
| ||
Positive surgical margin (%) | 120 (15) | 131 (13) |
| ||
Median UF or EF score at 12 mo† | 14.0 (11.0–15.0) | 8.0 (5.0–14.0) |
EF = erectile function; PSA = prostate-specific antigen, UF = urinary function.
All values are median (interquartile range) or frequency (proportion).
Median UF or EF score for those who did not recover function by 12 mo.